Have you conducted or contributed to economic evaluations in health research? You are invited to participate in a survey from the Ottawa Hospital Research Institute exploring patient and public engagement in economic evaluations.
The UK government is reportedly preparing to raise NICE’s cost-effectiveness threshold by 25%, as a bargaining chip to avoid US pharmaceutical tariffs. It’s time for health economists to reclaim this space and defend evidence-based decision-making.
Tony Culyer shares a selection of his collected aphorisms for health economists.
Chris Sampson challenges a recent article in The Lancet claiming that NICE recommendations reduce population health.
Chris shares his review of the summer 2024 HESG meeting at the University of Warwick, which was brimming with discussion of economic evaluation, career pathways, and the general election.
The goal of this workshop is to provide a platform for scholars conducting research on issues relating to discrimination and diversity to present their work and network with other experts in the field.
Prof Philip Clarke considers the challenge of reproducibility in the discipline of health economics, discussing several initiatives that can support high quality research and better decision-making.
An introduction to the work of Edgar Sydenstricker, a forgotten health economist who researched the 1918-20 influenza pandemic, the Great Depression, and inequalities in the impact of diseases such as pellagra.
Our authors provide regular round-ups of the latest peer-reviewed journals. We cover all issues of major health economics journals as well as other notable releases. Visit our journal round-up log to see past editions organised by publication title. If you’d… Read More »Journal round-up: Health Economics 31(7)
The pros and cons of setting the value of a cost-effectiveness threshold according to the marginal productivity of the healthcare service and the importance of deliberative decision-making.
